Laurie Stelzer

Insider Reports History

Location
San Diego, CA
Signature
Jennifer Fitzpatrick, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Laurie Stelzer:

Company Role Class Num Shares Value Price $ Report Date Ownership
Mirati Therapeutics, Inc. Chief Financial Officer Common Stock 102,312 $6,038,454 $59.02 09 Aug 2023 Direct
Mirati Therapeutics, Inc. Chief Financial Officer Employee Stock Option (Right to Buy) 45,456 20 Jan 2023 Direct
PMV Pharmaceuticals, Inc. Director Stock Option (right to buy) 33,500 05 Jun 2025 Direct
Spyre Therapeutics, Inc. Director Stock Option (Right to Buy) 25,000 29 May 2025 Direct
Surface Oncology, Inc. Director Stock Option (Right to Buy) 24,000 08 Jun 2022 Direct
Sionna Therapeutics, Inc. Director Non-Qualified Stock Option (right to buy) 19,959 12 Jun 2025 Direct
ARENA PHARMACEUTICALS INC EVP & Chief Financial Officer Common Stock 0 $98.51 11 Mar 2022 Direct
ARENA PHARMACEUTICALS INC EVP & Chief Financial Officer Employee Performance Restricted Stock Unit 0 11 Mar 2022 Direct
ARENA PHARMACEUTICALS INC EVP & Chief Financial Officer Employee Stock Option (right to buy) 0 11 Mar 2022 Direct

Insider Reports Filed by Laurie Stelzer

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SION Sionna Therapeutics, Inc. 12 Jun 2025 1 $0 4 Director 16 Jun 2025, 17:08
PMVP PMV Pharmaceuticals, Inc. 05 Jun 2025 1 $0 4 Director 09 Jun 2025, 16:30
SYRE Spyre Therapeutics, Inc. 29 May 2025 1 $0 4 Director 02 Jun 2025, 16:38
SION Sionna Therapeutics, Inc. 06 Feb 2025 0 $0 3 Director 06 Feb 2025, 21:22
PMVP PMV Pharmaceuticals, Inc. 06 Jun 2024 1 $0 4 Director 10 Jun 2024, 16:44
SYRE Spyre Therapeutics, Inc. 14 May 2024 1 $0 4 Director 16 May 2024, 16:10
SYRE Spyre Therapeutics, Inc. 22 Nov 2023 1 $0 4 Director 27 Nov 2023, 16:33
SYRE Spyre Therapeutics, Inc. 22 Nov 2023 0 $0 3 Director 27 Nov 2023, 16:27
/report/000162828023028889-stelzer-laurie-2023-08-09 Mirati Therapeutics, Inc. 09 Aug 2023 1 +$824,989 4 Chief Financial Officer 10 Aug 2023, 16:26
PMVP PMV Pharmaceuticals, Inc. 08 Jun 2023 1 $0 4 Director 12 Jun 2023, 17:55
/report/000162828023020720-stelzer-laurie-2023-06-02 Mirati Therapeutics, Inc. 02 Jun 2023 1 -$172,218 4 Chief Financial Officer 02 Jun 2023, 19:15
/report/000121465923001044-stelzer-laurie-2023-01-20 Mirati Therapeutics, Inc. 20 Jan 2023 2 $0 4 CFO 24 Jan 2023, 15:00
/report/000120919122036148-stelzer-laurie-2022-06-08 Surface Oncology, Inc. 08 Jun 2022 1 $0 4 Director 10 Jun 2022, 20:00
PMVP PMV Pharmaceuticals, Inc. 02 Jun 2022 1 $0 4 Director 06 Jun 2022, 17:59
/report/000121465922007823-stelzer-laurie-2022-06-01 Mirati Therapeutics, Inc. 01 Jun 2022 2 $0 4 CFO 03 Jun 2022, 17:56
/report/000121465922007057-stelzer-laurie-2022-05-16 Mirati Therapeutics, Inc. 16 May 2022 0 $0 3 CFO 16 May 2022, 17:01
/report/000162828022005891-stelzer-laurie-2022-03-11 ARENA PHARMACEUTICALS INC 11 Mar 2022 6 $0 4 EVP & Chief Financial Officer 11 Mar 2022, 15:12
/report/000162828022000340-stelzer-laurie-2022-01-03 ARENA PHARMACEUTICALS INC 03 Jan 2022 1 $0 4 EVP & Chief Financial Officer 05 Jan 2022, 16:00
/report/000120919121039462-stelzer-laurie-2021-06-08 Surface Oncology, Inc. 08 Jun 2021 1 $0 4 Director 10 Jun 2021, 16:30
PMVP PMV Pharmaceuticals, Inc. 02 Jun 2021 1 $0 4 Director 09 Jun 2021, 17:39